Bartłomiej Andrzej Sałapski

Bartłomiej Andrzej Sałapski

Auto-generated profile, based on publicly available information

Bartłomiej Andrzej Sałapski

Jan Kochanowski University, Kielce, Swietokrzyskie, Poland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
PKPiotr Komasara
Piotr Komasara
TSTomasz Szwarc
Tomasz Szwarc
MKMateusz Kałwik
Mateusz Kałwik
PMPaweł Mikołajczak
Paweł Mikołajczak
JNJulia Nowakowska
Julia Nowakowska
KNKarolina Niewczas
Karolina Niewczas
Introduction and purpose: Femoral neck fractures are a major source of morbidity and mortality among older adults, frequently leading to prolonged hospitalization, disability, and loss of independence. Vitamin D3 plays a central role in bone metabolism, muscle function, and immune modulation- all crucial for postoperative recovery. However, the clinical relevance of vitamin D3 status in patients undergoing surgery for femoral neck fractures remains incompletely understood. This narrative review aims to synthesize current evidence on the relationship between vitamin D3 levels and key outcomes including functional recovery, complication rates, and mortality in this population. Material and method: A comprehensive literature search was conducted in PubMed and Embase using Boolean operators and relevant medical subject terms. Filters limited the search to full-text, English-language studies published between 2020 and 2025 involving human subjects. In Embase, only randomized controlled trials and systematic reviews were included. A total of 98 non-duplicate studies were screened; 34 were selected for full-text analysis and thematic synthesis. Results: Most studies demonstrate a positive association between sufficient 25(OH)D levels and faster mobility recovery, improved functional scores (e.g., Harris Hip Score, Barthel Index), and better postoperative quality of life. Vitamin D3 deficiency is consistently linked to higher rates of infectious complications, delayed fracture healing, and increased fall risk. Several studies also associate low 25(OH)D levels with elevated short-term mortality. Supplementation strategies appear beneficial, although optimal dosing and timing remain under debate. Conclusions: Vitamin D3 status is a potentially modifiable factor influencing outcomes after femoral neck fracture surgery. Routine screening and appropriate supplementation should be considered as part of multidisciplinary perioperative care. Further randomized trials are needed to define causal relationships and refine clinical protocols.

31 August 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
DBDominika Weronika Brożyna
Dominika Weronika Brożyna
JDJarosław Dudek
Jarosław Dudek
WKWojciech Kukiełka
Wojciech Kukiełka
DGDamian GręBosz
Damian GręBosz
WKWiktoria Komornik
Wiktoria Komornik
WZWiktor Zdeb
Wiktor Zdeb
Introduction and Aim: Acne vulgaris is among the most prevalent dermatological conditions affecting adolescents and young adults. Visible acne lesions may considerably reduce quality of life, negatively influence self-esteem, and impair social functioning. Oral isotretinoin is widely considered the treatment of choice for severe and therapy-resistant acne. Nevertheless, concerns have long been raised regarding its potential association with psychiatric symptoms, particularly mood disturbances, depression, and suicidal behaviour. The purpose of this review is to summarise current clinical evidence concerning the relationship between isotretinoin therapy and mood disorders in patients with acne vulgaris, with particular attention to factors that may explain the observed clinical outcomes. Material and Methods: A narrative literature review was performed using advanced searches in the PubMed database. The analysis included English-language publications from the last five years, such as clinical and observational studies, systematic reviews, and meta-analyses focusing on depressive symptoms, psychiatric adverse events, and quality-of-life changes among patients receiving isotretinoin for acne vulgaris. Conclusions: The currently available evidence does not conclusively demonstrate a clinically meaningful increase in depression risk in the general population of patients treated with isotretinoin. However, in some individuals, specific vulnerability factors may increase susceptibility to mood disturbances, supporting the need for careful psychological monitoring during therapy. In many patients, improvement in acne severity is accompanied by better well-being and enhanced quality of life. Further research is required to clarify the neurobiological mechanisms underlying isotretinoin activity and to identify patients at greatest risk of psychiatric complications. These findings emphasize the importance of individualized risk–benefit assessment and close cooperation between dermatologists, general practitioners, and mental health specialists.

2 March 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MPMichalina Pastuszka
Michalina Pastuszka
KNKamil Nieroda
Kamil Nieroda
BSBartłomiej Andrzej Sałapski
Bartłomiej Andrzej Sałapski
AOAleksandra Małgorzata Obarzanek
Aleksandra Małgorzata Obarzanek
MNMichał Nowak
Michał Nowak
KSKatarzyna Anna Sobczyk
Katarzyna Anna Sobczyk
Long-duration, high-intensity endurance exercise places unique stress on the gastrointestinal tract. In competitive endurance disciplines such as triathlon, repeated exposure to prolonged exertion, heat strain, and dehydration can disturb normal gastrointestinal physiology. A key response to intense exercise is redistribution of blood flow away from the splanchnic circulation toward working muscles and thermoregulatory tissues, which may reduce intestinal perfusion. When this reduction is marked or sustained, it can contribute to mucosal injury, and subsequent restoration of blood flow may further intensify damage through inflammatory and oxidative processes. These mechanisms can weaken epithelial tight junctions, increase intestinal permeability, and promote translocation of luminal microbial products, potentially amplifying systemic inflammatory responses. Clinically, such changes are reflected by the high prevalence of gastrointestinal symptoms during training and competition, which may limit fueling tolerance and impair performance. In rare cases, more severe outcomes such as ischemic colitis or gastrointestinal bleeding may occur. The aim of this narrative review is to summarize current evidence on how long-duration, high-intensity endurance exercise affects small and large intestinal perfusion, epithelial barrier integrity, and gut microbial ecology in competitive athletes, and to discuss the practical significance of these alterations for symptoms, performance, and adverse gastrointestinal events. Results: Prolonged high-intensity endurance exercise markedly reduces splanchnic perfusion, predisposing the intestine to hypoperfusion and ischemia–reperfusion–related oxidative and inflammatory injury. Therefore, epithelial integrity may be compromised through tight junction disruption and enterocyte damage, resulting in increased intestinal permeability (“leaky gut”) and facilitating translocation of luminal bacterial components with subsequent immune activation. In addition, repeated endurance training and sport-specific dietary patterns appear to modulate gut microbiota composition and function, and some exercise-associated microbial shifts may correlate with metabolic adaptation and endurance performance. Materials and methods: reviewing recent literature research up to 15 years ago based PubMED, Google scholar reaserche based on following key words: leaky gut syndrome in athletes, gut microbiota in athletes, ischemic colitis in athletes.

20 August 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
JNJulia Nowakowska
Julia Nowakowska
MKMilena Karolina Krawczyk
Milena Karolina Krawczyk
PKPiotr Komasara
Piotr Komasara
TSTomasz Szwarc
Tomasz Szwarc
MKMateusz Kałwik
Mateusz Kałwik
DŻDominika Żyła
Dominika Żyła
Introduction and purpose: Gut microbiota has emerged as a key regulator of metabolic homeostasis. Incretin-based therapies such as semaglutide, liraglutide and tirzepatide not only improve glycemic control and promote weight loss, but may also exert systemic effects through microbiota modulation. This narrative review aims to compare the gut microbiota-related effects of these agents based on current preclinical and clinical evidence. Material and method: A systematic search of PubMed and Web of Science databases was conducted for full-text studies published between 2020 and 2025. Inclusion criteria encompassed original research in humans and animals evaluating the impact of semaglutide, liraglutide or tirzepatide on gut microbiota. From 136 initial results, 30 eligible studies were included after removing duplicates and applying inclusion criteria. Results: All three agents promoted increases in beneficial taxa such as Akkermansia muciniphila and SCFA-producing bacteria, and reduced pro-inflammatory genera. Semaglutide was associated with neuroimmune modulation, liraglutide with renal and hepatic benefits, while tirzepatide induced broader taxonomic shifts and diversity restoration, likely due to dual receptor agonism. Most findings derive from animal models, with limited human data available. Conclusions: Semaglutide, liraglutide and tirzepatide demonstrate both shared and distinct microbiota-modulating properties, which may partly mediate their therapeutic effects. Further clinical studies integrating microbiota profiling and metabolic outcomes are needed to validate these findings and support microbiota-informed treatment strategies.

28 August 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MWMateusz WnęK
Mateusz WnęK
MŁMichał Adam Łebek
Michał Adam Łebek
WKWiktoria Zofia Komornik
Wiktoria Zofia Komornik
JPJakub Jan Piec
Jakub Jan Piec
DGDamian GręBosz
Damian GręBosz
JGJakub Dawid Gałwiaczek
Jakub Dawid Gałwiaczek
Background. Long-term opioid therapy for chronic non-cancer pain is associated with numerous adverse effects, including psychological distress, dependence, and impaired functioning. In response to growing concerns about opioid-related harms, opioid deprescribing and tapering strategies have gained increasing attention in clinical practice. However, their impact on patients’ mental health and social functioning remains incompletely understood. Aim. This review aimed to evaluate the available evidence on the effects of opioid deprescribing and tapering on mental health and social functioning in patients with chronic non-cancer pain. Material and methods. A literature review was conducted using major biomedical databases, including PubMed, MEDLINE, Scopus, Web of Science, and the Cochrane Library. Eligible studies included peer-reviewed articles examining opioid deprescribing or tapering in adults with chronic non-cancer pain and reporting outcomes related to mental health, social functioning, or patient-reported functioning Results. The available evidence suggests that patients undergoing opioid deprescribing frequently present with substantial psychological distress, including depression, anxiety, and pain catastrophizing. Mental health outcomes during tapering are heterogeneous and influenced by the pace of dose reduction, patient involvement in decision making, and access to psychological support. Qualitative studies commonly highlight social factors: stigma, communication with healthcare providers, and availability of alternative pain management strategies. Conclusions. Opioid deprescribing in patients with chronic non-cancer pain represents a complex clinical process with potential implications for both mental health and social functioning. Individualized tapering strategies, patient involvement in treatment decisions, and adequate psychological and multidisciplinary support appear essential for minimizing adverse outcomes and improving patient experiences during opioid dose reduction.

7 August 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
AJAngelika Juszczyk
Angelika Juszczyk
SPSylwia Pietrajtis
Sylwia Pietrajtis
BSBartłomiej Sałapski
Bartłomiej Sałapski
DBDominika Brożyna
Dominika Brożyna
MKMateusz Kubicki
Mateusz Kubicki
KLKrzysztof Lis
Krzysztof Lis
Background: Polycystic ovary syndrome (PCOS) is a common hormonal disorder among women of reproductive age. Insulin resistance and obesity are frequent components of this syndrome and further worsen the associated hormonal disturbances and infertility. Aim: The aim of this narrative review is to explore the potential role of GLP-1 receptor agonists (GLP-1 RAs) in the management of women with PCOS, with particular focus on their effects on blood glucose fluctuations and excess body weight, both of which are important targets in PCOS treatment. Methods: The literature search was conducted using the PubMed database in order to find articles reporting on the mechanism of action of GLP-1 RAs, the results of their use in PCOS treatment, and their adverse effects. The authors included articles published between 2020 and 2026. Results: GLP-1 RAs exhibit pleiotropic metabolic effects, including the regulation of insulin and glucagon secretion, protective effects on pancreatic beta-cells, and modulation of appetite and energy intake. These mechanisms may contribute to the beneficial clinical outcomes observed in women with PCOS. Current clinical studies and meta-analyses have demonstrated the positive effects of GLP-1 RAs on anthropometric parameters, glucose metabolism, and selected reproductive and hormonal functions, particularly when used in combination with metformin. Adverse effects associated with these agents are mainly gastrointestinal and generally diminish over the course of treatment. Conclusions: GLP-1 RAs appear to represent a promising therapeutic approach for women with PCOS. However, further studies are required to evaluate the long-term effects of their use in this patient population.